TACTICS OF MANAGEMENT OF PATIENTS WITH FUNCTIONAL DYSPEPSIA IN THE CONTEXT OF THE ROME CONSENSUS IV


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents the tactics of management of patients with functional dyspepsia (FD) in the light of the main provisions of the Rome Consensus IV. It is concluded that the process of diagnosis and treatment of PD is quite expensive, requiring a broad aspect of knowledge on related pathology. Carrying out complete diagnostic and treatment programs should be substantiated and focused on the patient. Treatment of FD is time-consuming process and requires effort from both the physician and the patient. It is aimed to achieve an optimal quality of life.

Full Text

Restricted Access

About the authors

M. A Osadchuk

FSBEI HE «First Moscow State Medical University n.a. I.M. Sechenov» of RMH

Email: osadchuk.mikhail@yandex.ru
MD, Prof., Head of the Department of Outpatient Therapy of the Medical Faculty Moscow

D. V Balashov

FSBEI HE «First Moscow State Medical University n.a. I.M. Sechenov» of RMH

Moscow

M. M Osadchuk

SBHCI «City Polyclinic № 52» of Moscow Healthcare Department

References

  1. Drossman D.A. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology. 2016;150:1262-79.
  2. Stanghellini V., Chan F.K.L., Hasler W.L. et al. Gastroduodenal Disorders. Gastroenterology. 2016;150:1380-92.
  3. Chirila I., Morariu I.D., Barboi O.B., Drug V.L. The role of diet in the overlap between gastroesophageal reflux disease and functional dyspepsia. Turk J. Gastroenterol. 2016; 27:73-80.
  4. DiBaise J.K., Patel N., Noelting J., Dueck A.C., Roarke M., Crowell M.D. The relationship among gastroparetic symptoms, quality of life, and gastric emptying in patients referred for gastric emptying testing. Neurogastroenterol. Motil. 2016;28:234-42.
  5. Mahadeva S., Yadav H., Everett S.M., Goh K.L. Economic impact of dyspepsia in rural and urban malaysia: a population-based study. J. Neurogastroenterol Motil. 2012;18:43-57.
  6. Talley N.J., Tack J., Ptak T., Gupta R., Giguère M. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut. 2008; 57:740-46.
  7. Miwa H., Kusano M., Arisawa T., et al. Evidence-based clinical practice guidelines for functional dyspepsia. J. Gastroenterol. 2015; 50(2):125-39.
  8. Mahadeva S., Goh K.L. Epidemiology of functional dyspepsia: a global perspective. World J. Gastroenterol. 2006;12:2661-666.
  9. Dibaise J.K., Islam R.S., Dueck A.C., Roarke M.C., Crowell M.D. Psychological distress in Rome III functional dyspepsia patients presenting for testing of gastric emptying. Neurogastroenterol. Motil.2016;28:196-205.
  10. Zybach K., Friesen C.A., Schurman J.V. Therapeutic effect of melatonin on pediatric functional dyspepsia: A pilot study. World J. Gastrointest Pharmacol. Ther. 2016;7:156-61.
  11. Shimura S., Ishimura N., Mikami H., Okimoto E., Uno G., Tamagawa Y., Aimi M., Oshima N., Sato S., Ishihara S., et al. Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders. J. Neurogastroenterol. Motil. 2016;22:60-8.
  12. Peng Y.C., Huang L.R., Shyu C.L., Cheng C.C., Ho S.P. Interaction of omeprazole and Helicobacter pylori-induced nuclear factor-KB activation and mediators in gastric epithelial cells. J. Chin. Med. Assoc.2014;77:567-72.
  13. Bakshi S.S. Outcome evaluation of clarithromycin, metronidazole and lansoprazole regimens in Helicobacter pylori positive or negative children with resistant otitis media with effusion. J. Laryngol. Otol. 2016;130:318.
  14. Chen H., Dang Y., Zhou X., Liu B., Liu S., Zhang G. Tailored therapy versus empiric chosen treatment for helicobacter pylori eradication: a meta-analysis. Medicine (Baltimore). 2016; 95:e2750.
  15. Welsh C., Jarrin J., Daneman A., Belik J. In vivo ultrasound assessment of gastric emptying in newborn mice. J. Pediatr. Gastroenterol. Nutr. 2015;60:322-26.
  16. Kubo T.T., Moraes E.R., Secaf M., Troncon L.E. A novel dynamic scintigraphic technique for assessing duodenal contractions during gastric emptying in humans: a feasibility study. Nucl. Med. Commun. 2015;36:95-101.
  17. Zhang C.L., Geng C.H., Yang Z.W., Li Y.L., Tong L.Q., Gao P., Gao Y.Q. Changes in patients' symptoms and gastric emptying after Helicobacter pylori treatment. World J. Gastroenterol. 2016;22(18):4585-93.
  18. Pauwels A., Altan E., Tack J. The gastric accommodation response to meal intake determines the occurrence of transient lower esophageal sphincter relaxations and reflux events in patients with gastroesophageal reflux disease. Neurogastroenterol. Motil. 2014;26:581.
  19. Vakil N., Stelwagon M., Shea E.P., Miller S. Symptom burden and consulting behavior in patients with overlapping functional disorders in the US population. United Eur. Gastroenterol. J. 2016;4(3):413-22.
  20. Jamil O., Sarwar S., Hussain Z., Fiaz R.O., Chaudary R.D. Association Between Functional Dyspepsia and Severity of Depression. J. Coll. Physicians Surg. Pak. 2016; 26(6):513-16.
  21. Naumann J. Effect of Amitriptyline and Escitalopram on Functional Dyspepsia. Gastroenterology. 2016;150:532.
  22. Takagi A., Yanagi H., Ozawa H., Uemura N., Nakajima S., Inoue K., Kawai T., Ohtsu T., Koga Y. Effects of Lactobacillus gasseri OLL2716 on Helicobacter pylori-Associated Dyspepsia: A Multicenter Randomized Double-Blind Controlled Trial. Gastroenterol. Res. Pract. 2016;2016:7490452.
  23. Ianiro G., Pizzoferrato M., Franceschi F., Tarullo A., Luisi T., Gasbarrini G. Effect of an extra-virgin olive oil enriched with probiotics or antioxidants on functional dyspepsia: a pilot study. European Review for Medical and Pharmacological Sciences. 2013;17(15): 2085-90.
  24. Dang Y., Reinhardt J. D., Zhou X., Zhang G. The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a meta-analysis. PLoS ONE. 2014;9(11, article e111030) doi: 10.1371/journal. pone.0111030.
  25. European Medicines Agency. Pharmacovigilance Risk Assessment Committee (PRAC), Assessment report. Domperidone-containing medicinal products, 2014. Availablefrom:ttp://www.ema. europa.eu/docs/en_GB/document_library/ Referrals_document/Domperidone_31/ Recommendation_provided_by_ Committee/WC500168926.pdf.
  26. Medicines and Healthcare products Regulatory Agency. Domperidone: risks of cardiac side effects. Drug Safety Update. 2014;7(10). Available from: https://www.gov.uk/drug-safety-update/domperidone-risks-of-cardiac-side-effects.
  27. Мязин Р.Г. Сравнение прокинетиков итоприда и домперидона при лечении пациентов с гастроэзофагеальной рефлюксной болезнью и пациентов с функциональной диспепсией. РМЖ. 2010;6:355-59.
  28. Hall W. Improving the safety of prescriptions of domperidone in primary care: implementing MHRA advice. BMJ Qual Improv Rep. 2016;5(1):u209711.w4039.
  29. Huang X., Lv B., Zhang S., Fan Y.H., Meng L.N. Itopride therapy for functional dyspepsia: A meta-analysis. World J. Gastroenterol. 2012;18(48):7371-377.
  30. Matsueda K., Hongo M., Tack J., Saito Y., Kato H. A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut. 2012;61(6):821-28.
  31. Nicholas J. Talley. Functional dyspepsia: new insights into pathogenesis and therapy. Korean J. Intern. Med. 2016;31(3):444-56.
  32. Koloski N.A., Jones M., Talley N.J. Investigating the directionality of the brain-gut mechanism in functional gastrointestinal disorders. Gut. 2012;61:1776-777.
  33. Talley N.J., Locke G.R., Saito Y.A., et al. Effect of amitriptyline and escitalopram on functional dyspepsia: a multicenter, randomized controlled study. Gastroenterology. 2015;149:340-49.
  34. Yaoyao Lu, Meng Chen, Zhiyin Huang, and Chengwei Tang. Antidepressants in the Treatment of Functional Dyspepsia: A Systematic Review and Meta-Analysis. PLoS One. 2016;11(6):e0157798.
  35. Singh H., Bala R., Kaur K. Efficacy and tolerability of levosulipride, domperidone and metoclopramide in patients with non-ulcer functional dyspepsia: a comparative analysis. J. Clin. Diagn. Res. 2015;9(4):FC09-12.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies